Rachel Vatnsdal Analyst Performance

Senior Equity Research Analyst at JPMorgan Chase & Co.

Rachel Vatnsdal is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 12 publicly traded companies. Over the past year, Rachel Vatnsdal has issued 15 stock ratings, including buy, hold, and sell recommendations. While full access to Rachel Vatnsdal's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Rachel Vatnsdal's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 15 Last 0 Years
Buy Recommendations: 46.67% 7 Buy Ratings
Companies Covered: 12 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	46.7%	7 ratings
Hold	40.0%	6 ratings
Sell	13.3%	2 ratings

Out of 15 total stock ratings issued by Rachel Vatnsdal at JPMorgan Chase & Co., the majority (46.7%) have been Buy recommendations, followed by 40.0% Hold and 13.3% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	58.3% of companies on NASDAQ	7 companies
NYSE	41.7% of companies on NYSE	5 companies

Rachel Vatnsdal, an analyst at JPMorgan Chase & Co., currently covers 12 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 11 companies	91.7%
	Transportation 1 company	8.3%

Rachel Vatnsdal of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on Transportation companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 4 companies	33.3%
MEDICAL SERVICES 2 companies	16.7%
MEDICAL INFO SYS 2 companies	16.7%
MED/DENTAL - SUPP 1 company	8.3%
EQUIPMENT RENTAL & LEASING 1 company	8.3%
MED INSTRUMENTS 1 company	8.3%
MED PRODUCTS 1 company	8.3%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
HSIC Henry Schein	8/7/2025	Lower Price Target	$65.90	$76.00	Overweight
ADPT Adaptive Biotechnologies	8/6/2025	Boost Price Target	$11.69	$14.00	Overweight
AVTR Avantor	8/4/2025	Lower Price Target	$11.42	$14.00	Overweight
CAI CAI International	7/14/2025	Initiated Coverage	$26.51	$31.00	Overweight
TXG 10x Genomics	5/9/2025	Lower Price Target	$8.87	$9.00	Neutral
TWST Twist Bioscience	5/6/2025	Lower Price Target	$35.93	$33.00	Underweight
RVTY Revvity	4/29/2025	Lower Price Target	$94.46	$100.00	Neutral
RGEN Repligen	4/29/2025	Lower Price Target	$139.43	$190.00	Overweight
WAT Waters	3/6/2025	Boost Price Target	$387.06	$390.00	Neutral
NVST Envista	3/6/2025	Lower Price Target	$17.93	$19.00	Neutral
TEM Tempus AI	2/25/2025	Downgrade	$69.57	$55.00	Neutral
RGEN Repligen	2/21/2025	Boost Price Target	$161.11	$200.00	Overweight
GH Guardant Health	2/21/2025	Boost Price Target	$46.42	$55.00	Overweight
TXG 10x Genomics	2/13/2025	Lower Price Target	$11.39	$12.00	Neutral
TWST Twist Bioscience	2/4/2025	Boost Price Target	$51.99	$40.00	Underweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.